Raw 264.7 Whole Cell - T0901317 treated: Activity Assays
Treatment with liver X receptor (LXR) agonists like benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide], or more commonly known as T0901317 (T09), lowers the cholesterol level in serum and liver and inhibits the development of atherosclerosis in murine disease models. T09 modulates cholesterol metabolism and inhibits inflammation.
Show More
1 result for "Raw 264.7 Whole Cell - T0901317 treated Activity Assays" in Products
1 result for "Raw 264.7 Whole Cell - T0901317 treated Activity Assays" in Products
Raw 264.7 Whole Cell - T0901317 treated: Activity Assays
Treatment with liver X receptor (LXR) agonists like benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide], or more commonly known as T0901317 (T09), lowers the cholesterol level in serum and liver and inhibits the development of atherosclerosis in murine disease models. T09 modulates cholesterol metabolism and inhibits inflammation.
Show More
| Applications: | WB |
![Western Blot: Raw 264.7 Whole CellT0901317 treated Assay Kit [NBP1-30159]](https://resources.bio-techne.com/images/products/Raw-264.7-Whole-Cell-T0901317-treated-Kit-Western-Blot-NBP1-30159-img0003.jpg "Western Blot: Raw 264.7 Whole CellT0901317 treated Assay Kit [NBP1-30159]")